Health Care

APM Human Services International (APM) has acquired physiotherapy and home care group Lifecare for $68 million.

Resonance Health (RHT) has submitted its LiverSmart device to the Food and Drug Administration (FDA) for US regulatory clearance.

Dotz Nano (DTZ) has entered into a distribution agreement with ScienceVision to promote, sell and distribute its COVID-19 virus detection technology in Malaysia.

Kazia Therapeutics (KZA) has opened the trading day green after reporting positive final results from a second-phase clinical study of its paxalisib drug

Starpharma (SPL) has signed an ongoing distribution arrangement to launch VIRALEZE in Vietnam.

Alcidion (ALC) has been awarded a six-year contract for a healthcare IT project for the Commonwealth of Australia.

Amplia Therapeutics (ATX) has been granted a $2.1 million Research and Development (R&D) cash flow loan.

Halucenex Life Sciences, a subsidiary of Creso Pharma (CPH), has secured an amendment to its Controlled Drugs and Substances Dealer’s Licence.

Immutep (IMM) has treated five patients in its study evaluating eftilagimod (efti) alpha in conjunction with standard of care chemotherapy.

Zelira Therapeutics (ZLD) has received ethics approval for its Phase 2a clinical trial for chronic pain.